167 related articles for article (PubMed ID: 12375053)
1. Effects of pentosan polysulfate sodium on the estrogen-induced pituitary prolactinoma in Fischer 344 rats.
Mucha S; Melen-Mucha G; Stepien T; Godlewski A; Stepien H
Oncol Rep; 2002; 9(6):1385-9. PubMed ID: 12375053
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
Gruszka A; Pawlikowski M; Kunert-Radek J
Neuro Endocrinol Lett; 2001 Oct; 22(5):343-8. PubMed ID: 11600876
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
[TBL] [Abstract][Full Text] [Related]
5. The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.
Pandey J; Bannout A; Wendell DL
Carcinogenesis; 2004 Oct; 25(10):1829-38. PubMed ID: 15166088
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2006 Apr; 40(3):230-5. PubMed ID: 16499559
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
9. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
Nguyen NM; Lehr JE; Pienta KJ
Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2007 Mar; 42(2):172-9. PubMed ID: 17286750
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced pituitary tumor development in the ACI rat not inhibited by dietary energy restriction.
Spady TJ; Pennington KL; McComb RD; Birt DF; Shull JD
Mol Carcinog; 1999 Dec; 26(4):239-53. PubMed ID: 10569801
[TBL] [Abstract][Full Text] [Related]
12. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Wass JA; Harris AL
Br J Cancer; 2000 Apr; 82(8):1441-5. PubMed ID: 10780524
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
Gruszka A; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
[TBL] [Abstract][Full Text] [Related]
14. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
[TBL] [Abstract][Full Text] [Related]
15. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
Nickel JC; Forrest JB; Tomera K; Hernandez-Graulau J; Moon TD; Schaeffer AJ; Krieger JN; Zeitlin SI; Evans RJ; Lama DJ; Neal DE; Sant GR
J Urol; 2005 Apr; 173(4):1252-5. PubMed ID: 15758763
[TBL] [Abstract][Full Text] [Related]
16. The importance of dopamine in the pathogenesis of experimental prolactinomas.
el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of pentosan polysulfate against malignant breast cells.
Zaslau S; Riggs DR; Jackson BJ; Adkins FC; John CC; Kandzari SJ; McFadden DW
Am J Surg; 2004 Nov; 188(5):589-92. PubMed ID: 15546576
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
[TBL] [Abstract][Full Text] [Related]
19. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol-induced prolactinoma: dose-related tumor growth and effect of catecholaminergic cells on prolactin tumor cells.
Palaoğlu S; Sungur A; Cila A; Ozdemir N; Ruacan S
Surg Neurol; 2005; 64 Suppl 2():S42-7. PubMed ID: 16256840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
